Form D · Other Technology

MedTrans Go, Inc.

Atlanta, GA · CIK 0001900963

Offering snapshot reported Jan 26, 2024 · SEC filing

Reported sold
$2.87M
Offering amount: $4.83M
Investors reported
20
Form D · investor count
Minimum accepted
$48.7K
Reported outside-investor minimum
First sale
Sep 2, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.44M$2.87MJan 25, 2023: $2,325,999.00Jan 25, 2023Jan 26, 2024: $2,871,003.00Jan 26, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,325,999 → $2,871,003
  • Reported investors14 → 20

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 26, 2024Amendment$2,871,003$545,004vs Jan 25, 202320SEC filing
Jan 25, 2023Initial$2,325,999No comparison14SEC filing
Dec 23, 2021Initial$2,555,445No comparison21SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-471743

Source: Form D, filed Jan 26, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ben Brantly Director
Mike Dunn Director
Obi Ugwonali Director, Executive
Adanna Ugwonali Director
Dana Weeks Director, Executive
Dana Weeks Ugwonali Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
75 5 Th Street Nw Suite 2140
Atlanta, GA, 30308